Cashu FinanceCashu Finance
  • Terminal
  • Spotlight
  • Cashu Research
Log inSign Up
← Back to Terminal
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. URGN

Market Cap: $1.66B

UL

UroGen Pharma Ltd.

URGN
NASDAQUSD
Purchase URGN
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutive
Cashu FinanceCashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Research is part of Cashu Technology Pty Ltd, which is an authorised representative (AR # 001318029) of Adviser Solutions Group Pty Ltd (ABN 88 601 875 521) (AFSL 485946) (ASG).

This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by Cashu Technologies Pty Ltd, any of their related body corporates or any other person. To the maximum extent possible, Cashu Technologies Pty Ltd, their related body corporates or any other person do not accept any liability for any statement in this material.

Financials

Profitability
Gross Profit Margin90.85%
EBITDA Margin-37.16%
EBIT Margin-38.55%
Pre-tax Margin-51.98%
Net Profit Margin-51.73%
Earnings Yield-5.69%
Valuation Multiples
Price / Book-12.95
Price / Sales8.82
Price / Earnings-17.19
PEG-0.34
Forward PEG0.18
EV / Sales9.44
EV / EBITDA-25.40
EV / Operating Cash Flow-11.21
EV / Free Cash Flow-11.19
Price / Free Cash Flow-10.46
Price / Operating Cash Flow-10.79
Cash Flow & Capital
Free Cash Flow / Share-$3.16
Operating Cash Flow / Share-$3.15
Free Cash Flow Yield-9.56%
Capex / Revenue0.12%
Capex / Operating Cash Flow-0.14%
Capex / Depreciation0.08
Stock Compensation / Revenue8.54%
Dividend Payout Ratio0.00%
Dividend Yield0.00%
Liquidity & Leverage
Current Ratio3.80
Quick Ratio3.41
Cash Ratio1.28
Debt / Assets0.78
Debt / Capital3.08
Debt / Equity-1.48
Long-Term Debt / Capital3.35
Debt / Market Cap11.34%
Net Debt / EBITDA-1.67
Solvency Ratio-0.25
Financial Leverage-1.91
Efficiency & Working Capital
Asset Turnover0.75
Fixed Asset Turnover22.95
Inventory Turnover0.70
Receivables Turnover2.13
Payables Turnover0.43
Days Sales Outstanding171.65
Days Inventory Outstanding519.45
Days Payables Outstanding843.84
Operating Cycle691.1
Cash Conversion Cycle-152.75
Working Capital Turnover1.05
Returns & Quality
Return on Equity81.78%
Return on Assets-38.65%
Return on Invested Capital-34.41%
ROCE-34.96%
Return on Tangible Assets-38.65%
Operating Return on Assets-26.33%
Income Quality1.63
Tax Burden1.00
Interest Burden1.35
Balance Sheet & Intrinsic Metrics
Enterprise Value$1.78B
Invested Capital$181.74M
Working Capital$173.51M
Tangible Asset Value$-132.4M
Net Current Asset Value$-149.56M
Graham Net-Net-$3.93
Book Value / Share-$2.63
Tangible Book Value / Share-$2.63
Cash / Share$2.14
Financial Health Scores
Piotroski Score2
Altman Z-Score-2.28
Revenue$188.73M
EBIT$-72.76M
Market Cap$1.69B
Working Capital$173.51M
Retained Earnings$-997.64M
Total Assets$252.59M
Total Liabilities$384.99M